← Leaderboards
Mitchell J. Frederick
University Of Tx Md Anderson Can Ctr
$5,632,139
Attributed
$10,995,423
Total exposure
4
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2015–25$2M$1.5M$1M$500K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$10,995,423 · 4
By mechanism
R01$7,152,756 · 3
U01$3,842,667 · 1
Top collaborators
- Faye Johnson5 shared
- Abdullah Ali Osman5 shared
- Olivier Lichtarge4 shared
- Jeffrey Nicholas Myers4 shared
- Filip Janku2 shared
Most similar at University Of Tx Md Anderson Can Ctr
Same institution · by research overlap
- Heath Devin Skinner$8,539,031
- Faye Johnson$4,125,981
- Abdullah Ali Osman$1,994,753
- John V. Heymach$11,138,593
- Erich M Sturgis$2,392,613
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsNotch1 GeneGenomicsGenesLinkHead And Neck Squamous Cell CarcinomaTumorMolecularTumor Suppressor ProteinsCell LineCessation Of LifeProteinsSurvival RateDrug TargetingPharmaceutical PreparationsNew Therapeutic TargetGrowthIn VitroDna Sequence AlterationMutationMutateCellsOncogenesPathway Interactions
Grant awards (19)
Targeting replication stress and homologous recombination repair mechanisms in HPV-positive and negative head and neck cancer$383,497
R01 · FY2025 · DE
Targeting replication stress and homologous recombination repair mechanisms in HPV-positive and negative head and neck cancer$375,860
R01 · FY2024 · DE
Targeting Alterations of the NOTCH1 Pathway in Head & Neck Squamous Cell Carcinoma (HNSCC)$637,606
R01 · FY2023 · CA
Targeting replication stress and homologous recombination repair mechanisms in HPV-positive and negative head and neck cancer$383,561
R01 · FY2023 · DE
Targeting Alterations of the NOTCH1 Pathway in Head & Neck Squamous Cell Carcinoma (HNSCC)$637,606
R01 · FY2022 · CA
Targeting replication stress and homologous recombination repair mechanisms in HPV-positive and negative head and neck cancer$379,754
R01 · FY2022 · DE
Targeting Alterations of the NOTCH1 Pathway in Head & Neck Squamous Cell Carcinoma (HNSCC)$650,759
R01 · FY2021 · CA
Targeting replication stress and homologous recombination repair mechanisms in HPV-positive and negative head and neck cancer$398,345
R01 · FY2021 · DE
Targeting Alterations of the NOTCH1 Pathway in Head & Neck Squamous Cell Carcinoma (HNSCC)$650,759
R01 · FY2020 · CA
Targeting Alterations of the NOTCH1 Pathway in Head & Neck Squamous Cell Carcinoma (HNSCC)$666,259
R01 · FY2019 · CA
Mechanisms and Consequences of NOTCH Dysfunction in Head and Neck Cancer$396,250
R01 · FY2019 · DE · contact PI
Translating genomic alterations into novel therapeutic targets in head and neck cancer through computational and functional approaches$957,000
U01 · FY2018 · DE
Mechanisms and Consequences of NOTCH Dysfunction in Head and Neck Cancer$396,250
R01 · FY2018 · DE · contact PI
Translating genomic alterations into novel therapeutic targets in head and neck cancer through computational and functional approaches$957,000
U01 · FY2017 · DE
Mechanisms and Consequences of NOTCH Dysfunction in Head and Neck Cancer$396,250
R01 · FY2017 · DE · contact PI
Translating genomic alterations into novel therapeutic targets in head and neck cancer through computational and functional approaches$957,000
U01 · FY2016 · DE
Mechanisms and Consequences of NOTCH Dysfunction in Head and Neck Cancer$400,000
R01 · FY2016 · DE · contact PI
Translating genomic alterations into novel therapeutic targets in head and neck cancer through computational and functional approaches$971,667
U01 · FY2015 · DE
Mechanisms and Consequences of NOTCH Dysfunction in Head and Neck Cancer$400,000
R01 · FY2015 · DE · contact PI